Endurance Wealth Management’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $19K | Hold |
625
| – | – | ﹤0.01% | 432 |
|
|
2023
Q1 | $19K | Hold |
625
| – | – | ﹤0.01% | 437 |
|
|
2022
Q4 | $24K | Hold |
625
| – | – | ﹤0.01% | 396 |
|
|
2022
Q3 | $30K | Hold |
625
| – | – | 0.01% | 374 |
|
|
2022
Q2 | $24K | Sell |
625
-100
| -14% | -$3.84K | ﹤0.01% | 394 |
|
|
2022
Q1 | $42K | Buy |
725
+100
| +16% | +$5.79K | 0.01% | 368 |
|
|
2021
Q4 | $49K | Hold |
625
| – | – | 0.01% | 353 |
|
|
2021
Q3 | $60K | Hold |
625
| – | – | 0.01% | 335 |
|
|
2021
Q2 | $57K | Hold |
625
| – | – | 0.01% | 346 |
|
|
2021
Q1 | $50K | Hold |
625
| – | – | 0.01% | 360 |
|
|
2020
Q4 | $51K | Sell |
625
-300
| -32% | -$24.5K | 0.01% | 326 |
|
|
2020
Q3 | $22K | Hold |
925
| – | – | ﹤0.01% | 377 |
|
|
2020
Q2 | $25K | Buy |
+925
| New | +$25K | ﹤0.01% | 375 |
|